The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA47209
Max Phase: Preclinical
Molecular Formula: C18H18F3N3O3
Molecular Weight: 381.35
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: CC1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)CCN1
Standard InChI: InChI=1S/C18H18F3N3O3/c1-8-6-23(5-4-22-8)16-13(20)12(19)11-15(14(16)21)24(9-2-3-9)7-10(17(11)25)18(26)27/h7-9,22H,2-6H2,1H3,(H,26,27)
Standard InChI Key: UVPAOMFBMNZWTA-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 381.35Molecular Weight (Monoisotopic): 381.1300AlogP: 2.25#Rotatable Bonds: 3Polar Surface Area: 74.57Molecular Species: ZWITTERIONHBA: 5HBD: 2#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 5.30CX Basic pKa: 8.68CX LogP: -0.18CX LogD: -0.19Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.80Np Likeness Score: -0.30
References 1. Miyamoto T, Matsumoto J, Chiba K, Egawa H, Shibamori K, Minamida A, Nishimura Y, Okada H, Kataoka M, Fujita M.. (1990) Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency., 33 (6): [PMID:2342057 ] [10.1021/jm00168a018 ]